Cargando…
Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis
BACKGROUND: Minimal change disease (MCD) and primary focal segmental glomerulosclerosis (FSGS) are glomerular diseases characterized by nephrotic syndrome. Their diagnosis requires a renal biopsy, but it is an invasive procedure with potential complications. In a small biopsy sample, where only norm...
Autores principales: | Pérez, Vanessa, López, Dolores, Boixadera, Ester, Ibernón, Meritxell, Espinal, Anna, Bonet, Josep, Romero, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291957/ https://www.ncbi.nlm.nih.gov/pubmed/28158993 http://dx.doi.org/10.1186/s12882-017-0452-6 |
Ejemplares similares
-
Urinary Peptide Profiling to Differentiate between Minimal Change Disease and Focal Segmental Glomerulosclerosis
por: Pérez, Vanessa, et al.
Publicado: (2014) -
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease
por: Chebotareva, Natalia V., et al.
Publicado: (2022) -
The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Mason, P D
Publicado: (1997) -
The Treatment of Minimal Change Nephropathy and Focal Segmental
Glomerulosclerosis
por: Milford, D V
Publicado: (1997) -
Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis
por: Fernandez-Juarez, Gema, et al.
Publicado: (2016)